| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/25/2013 | DE112011102362T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit neurodegenerativen Erkrankungen in Verbindung stehen A pharmaceutical combination composition and methods for treating diseases or conditions associated with neurodegenerative diseases in connection |
| 04/25/2013 | DE112011102358T5 Verfahren zur Erhöhung der Wirkung einer aktivierten-potenzierten Form eines Antikörpers A method for increasing the effect of an activated-potentiated form of an antibody |
| 04/25/2013 | DE112011102355T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von funktionellen Erkrankungen oder Zuständen des Gastrointestinaltraktes A pharmaceutical combination composition and methods for the treatment of functional disorders or conditions of the gastrointestinal tract |
| 04/25/2013 | CA2852800A1 A m-dc8+ monocyte depleting agent for the prevention or the treatment of a condition associated with a chronic hyperactivation of the immune system |
| 04/25/2013 | CA2852758A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
| 04/25/2013 | CA2852474A1 Antibodies directed against influenza |
| 04/25/2013 | CA2852145A1 Antagonists of il17c for the treatment of inflammatory disorders |
| 04/25/2013 | CA2851795A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | CA2851053A1 Separation method for fucosylated antibodies |
| 04/25/2013 | CA2850572A1 Stable multiple antigen-binding antibody |
| 04/25/2013 | CA2850534A1 Restricted immunoglobulin heavy chain mice |
| 04/24/2013 | EP2584043A2 Anti-glypican 3 antibody having improved kinetics in plasma |
| 04/24/2013 | EP2583981A2 Antibodies and related molecules that bind to PSCA proteins |
| 04/24/2013 | EP2583980A1 Antibodies directed against the alpha chain of IL7 receptor - their use for the preparation of drug candidates |
| 04/24/2013 | EP2583979A1 Antibodies directed against p19 subunit of human IL-23 - Use for the preparation of therapeutic molecules |
| 04/24/2013 | EP2583978A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 04/24/2013 | EP2583973A1 Method for purifying protein using amino acid |
| 04/24/2013 | EP2583550A1 Methods for generation of antibodies |
| 04/24/2013 | EP2582862A2 Methods and systems for generating, validating and using monoclonal antibodies |
| 04/24/2013 | EP2582796A2 Modified parvovirus having enhanced anti-tumour efficacy |
| 04/24/2013 | EP2582729A1 Anti-axl antibodies and methods of use |
| 04/24/2013 | EP2582728A2 Human antibody drug conjugates against tissue factor |
| 04/24/2013 | EP2582727A1 Antibodies to endoplasmin and their use |
| 04/24/2013 | EP2582726A1 Antibody derivatives |
| 04/24/2013 | EP2582725A2 Anti-dr4 agonist antibodies |
| 04/24/2013 | EP2582724A2 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof |
| 04/24/2013 | EP2582723A1 Assay for detecting frre light chains by capillary zone electrophoresis |
| 04/24/2013 | EP2582722A2 Anti-gd2 antibodies |
| 04/24/2013 | EP2582721A1 Antibodies useful in passive influenza immuization |
| 04/24/2013 | EP2582390A1 Immunotherapeutic method involving cd123 (il-3r ) antibodies and immunostimulating complex |
| 04/24/2013 | EP2582230A1 Animal models and therapeutic molecules |
| 04/24/2013 | EP2395022A9 LINGO binding molecules and pharmaceutical use thereof |
| 04/24/2013 | CN202898282U Ultra-filtration feeding device for processing of immunoglobulin yolk |
| 04/24/2013 | CN103068994A Mice expressing alight chain with human lambda variable and mouse constant regions |
| 04/24/2013 | CN103068993A Hybrid light chain mice |
| 04/24/2013 | CN103068852A Anti-human igg1 antibody |
| 04/24/2013 | CN103068851A Antibodies to endoplasmin and their use |
| 04/24/2013 | CN103068850A Single -chain variable fragment anti-cd133 antibodies and uses thereof |
| 04/24/2013 | CN103068849A Anti-bv8 antibodies and uses thereof |
| 04/24/2013 | CN103068848A Anti-n3pglu amyloid beta peptide antibodies and uses thereof |
| 04/24/2013 | CN103068847A Activatable bispecific antibodies |
| 04/24/2013 | CN103068846A Bispecific antibodies comprising a disulfide stabilized - fv fragment |
| 04/24/2013 | CN103068838A Vaccine against streptococcal infections based on recombinant proteins |
| 04/24/2013 | CN103068367A Compositions and methods for stabilizing protein-containing formulations |
| 04/24/2013 | CN103068365A Removal of serine proteases by treatment with finely divided silicon dioxide |
| 04/24/2013 | CN103068256A Ice crystallization inhibitor derived from basidiomycetes |
| 04/24/2013 | CN103060360A Prokaryotic expression vector of 14-3-3j protein gene of black soybean and application thereof |
| 04/24/2013 | CN103060275A Ketamine hybridoma cell strain and preparation method and application thereof |
| 04/24/2013 | CN103060274A RANKL-TNF sample region mouse monoclonal antibody and its preparation method and use |
| 04/24/2013 | CN103060273A Hybridoma cell strain for secreting SAMHD1 protein monoclonal antibody, monoclonal antibody secreted by cell strain and application |
| 04/24/2013 | CN103059138A Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| 04/24/2013 | CN103059137A Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity |
| 04/24/2013 | CN103059136A Preparation method of anti-pelodiscus-sinensis IL-1 beta polyclonal antibody and application thereof to detection |
| 04/24/2013 | CN103059135A A specific antibody of major royal jelly protein MRJP1 and a preparation method thereof and Elisa quantitative detection thereof |
| 04/24/2013 | CN103059134A Immune preparation method of antituberculous polypeptide |
| 04/24/2013 | CN103059133A Monoclonal antibody and antibody composition for neutralizing canine distemper virus (CDV) |
| 04/24/2013 | CN103059132A Monoclonal antibody of anti-H9 subtype flu virus haemagglutinin protein and application thereof |
| 04/24/2013 | CN103059131A Method for preparing bivalent yolk antibody for preventing and treating duck virus hepatitis I and III |
| 04/24/2013 | CN103059117A High throughput screening of important schistosoma japonicum antigens and application of antigens in schistosomiasis diagnosis |
| 04/24/2013 | CN103059110A Candida albicans apoptosis-promoting factor gene and application thereof |
| 04/24/2013 | CN103059103A Specific CD4+T cell epitope peptide of Hantaan virus nucleoprotein |
| 04/24/2013 | CN102321167B Antigen epitope peptide of alpha fetoprotein, nucleic acid, preparation method of nucleic acid, recombinant vector, host cell, hybridoma cell, monoclonal antibody and kit |
| 04/24/2013 | CN102286097B Synthetic pokeweed antiviral protein (PAP) antigen and antibody, and preparation method and application thereof |
| 04/24/2013 | CN102188704B Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 04/24/2013 | CN102146138B Monoclonal antibody of chloramphenicol and application thereof |
| 04/24/2013 | CN101985468B SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 04/24/2013 | CN101857866B Method for screening single chain antibodies of Microcystin-LR and verification thereof |
| 04/24/2013 | CN101410413B Anti-EPHRINB2 antiboies and methods using same |
| 04/24/2013 | CN101232896B Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 04/24/2013 | CN101184776B Novel anti-plgf antibody |
| 04/24/2013 | CN101160324B Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 04/23/2013 | US8426565 Dendritic cell marker and uses thereof |
| 04/23/2013 | US8426563 Antibody specific for B7-H5, a costimulatory polypeptide |
| 04/23/2013 | US8426560 Microwave-assisted peptide synthesis |
| 04/23/2013 | US8426557 IGF-1R binding polypeptides and their use |
| 04/23/2013 | US8426554 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
| 04/23/2013 | US8426144 Monocyte-derived nucleic acids and related compositions and methods |
| 04/23/2013 | US8426141 Methods for increasing the therapeutic efficacy of immunoglobulin G class 3 (IgG3) antibodies |
| 04/23/2013 | US8425910 Composition comprising antibodies to LINGO or fragments thereof |
| 04/23/2013 | US8425908 Treatment with anti-ErbB2 antibodies |
| 04/23/2013 | US8425903 Methods of treatment by administering antibodies to notch receptors |
| 04/23/2013 | US8425876 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof |
| 04/23/2013 | CA2575663C Antibodies directed against amyloid-beta peptide and methods using same |
| 04/23/2013 | CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 04/23/2013 | CA2493081C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 04/23/2013 | CA2422890C Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 04/23/2013 | CA2410153C A novel bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof |
| 04/23/2013 | CA2381125C Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/23/2013 | CA2351550C Phosphonate metabolizing plants |
| 04/23/2013 | CA2308571C Single-chain bifunctional glycoprotein hormones |
| 04/18/2013 | WO2013056068A1 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | WO2013055998A1 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE |
| 04/18/2013 | WO2013055958A1 Improved assembly of bispecific antibodies |
| 04/18/2013 | WO2013055874A2 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/18/2013 | WO2013055809A1 A method for purifying antibodies |
| 04/18/2013 | WO2013055404A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/18/2013 | WO2013054830A1 Monoclonal antibody against el, inhibiting el enzymatic activity |
| 04/18/2013 | WO2013054331A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/18/2013 | WO2013054250A1 Purification method |
| 04/18/2013 | WO2013054127A1 Canine/feline cd20 binding epitope and compositions for binding thereto |